An interventional study of Pistachio-enriched diet and Usual diet in Cognition, Cardiometabolic Risk Factors and Life Satisfaction, sponsored by Brigham and Women's Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Personal Satisfaction with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Personal Satisfaction · United States.
Among the 91 studies in Personal Satisfaction with a site in United States, this one is the 50th largest by enrollment of the 80 interventional ones that give a count, is one of 3 that started in 2025, is one of 65 with no phase, and was the 85th registered.
543 studies on the registry are indexed under Personal Satisfaction; 91 are open to participants now.
Browse Personal Satisfaction studies →6 of the 91 studies in Personal Satisfaction with a site in United States are open now. Recruiting first, the newest first:
Avant Health LLC · Sites in United States
Ages 18+
University of Colorado, Denver · Sites in United States
Ages 8–18
Belmont University · Sites in United States
Ages 18+ · Healthy volunteers
Indiana University · Sites in United States
Ages 18+
Oregon Research Behavioral Intervention Strategies, Inc. · Sites in United States
Ages 3–90 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 38 Personal Satisfaction studies recruiting now, 18 (47%) set no upper age limit and 15 (39%) stop at 75 or younger; 8 take children under 18; 20 take healthy volunteers.
This study: 65 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 97 is close to the median of 93 across 418 interventional studies indexed under Personal Satisfaction.
Median enrollment 117 across the 80 interventional studies, 83 across the 11 observational. Of the 75 that completed or were terminated, 20 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 91 have an industry lead sponsor. The 10 most frequent:
Brigham and Women's Hospital is the lead sponsor of 1,270 studies on the registry; 230 are open to participants now.
Of its 117 completed or terminated interventional studies of FDA-regulated products, 65 (56%) have results posted.
Brigham and Women's Hospital has 4 studies filed under Personal Satisfaction — fewer than ten, so there is no comparison to draw.
3 of the studies in Personal Satisfaction with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05110729University of Colorado, DenverQuality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury | 2026-11 |
| NCT06992544Brigham and Women's HospitalTrial of Pistachio Consumption in Older Adults | 2027-03 |
| NCT07228299Indiana UniversitySupporting Families in the ICU | 2027-11-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 91 studies in Personal Satisfaction with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to evaluate whether a pistachio-enriched diet leads to changes in cognitive function, cardiometabolic risk factors, and life satisfaction in older adults over a 6-month period.
In this remote-based, parallel-arm RCT, the investigators will recruit participants from the recently completed COcoa Supplement and Multivitamin Outcomes Study (COSMOS) trial cohort. Eligible COSMOS participants will be invited to participate in the proposed RCT, screened to verify eligibility and willingness to participate, and asked to provide informed consent. Eligible and willing participants will be enrolled and randomized on a rolling basis. Risk factors and Outcome assessments will be conducted at baseline, 3 months and 6 months via the MyCap Mobile Toolbox application, REDCap questionnaires (for life satisfaction, dietary, and other phenotypic assessments), or at a local Quest Diagnostics (for biospecimen collection and return to our biorepository).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1 packet/day of approximately 1.25 oz (35 g) of dry roasted, unsalted, shelled pistachio kernels
Other: Pistachio-enriched diet
Usual diet (while abstaining from pistachio consumption and limiting other nut consumption to ≤1 serving/week)
Other: Usual diet
1 packet/day of approximately 1.25 oz (35 g) of dry roasted, unsalted, shelled pistachio kernels
Usual diet (while abstaining from pistachio consumption and limiting other nut consumption to ≤1 serving/week)
Mobile Toolbox
The investigators will assess 6-month changes in the Mobile Toolbox (MTB) fluid cognition composite (FCC) score via MyCap. Participants will be instructed to install the MyCap app on their personal smartphones to complete the assessments. The FCC score considers the following domains (tests): associative memory (Face and Names), episodic memory (Arranging Pictures), working memory (Sequences), processing speed (Number-Symbol Match), and executive function (Arrow Matching for inhibitory control, Shape-Color Sorting for cognitive flexibility). The FCC score will be calculated by standardizing scores for each MTB test using means and standard deviations (SD) across the entire sample and averaging z-scores across the six tests (mean=0; SD=1). Higher FCC scores will indicate better cognitive function.
Time frame: Baseline and 6 months
Blood pressure
The investigators will assess 6-month changes in seated systolic and diastolic blood pressure (in mmHg).
Time frame: Baseline and 6 months
Life Satisfaction for the Third Age-Short Form
The investigators will assess 6-month changes in total score for the "Life Satisfaction for the Third Age-Short Form" questionnaire, a validated self-rated 12-item assessment of successful aging and psychological well-being among older adults. Participants will be instructed to select an answer that most closely reflect their attitude towards each statement on a Likert scale from 1 (strongly disagree) to 6 (strongly agree). Scores may range from 6-72, in which a higher score indicates greater life satisfaction.
Time frame: Baseline and 6 months
Shape-Color Sorting
The investigators will assess 6-month changes in the Mobile Toolbox "Shape-Color Sorting" test as a measure of cognitive flexibility, a component of executive function (individual cognitive domain). Participants are primary scored on rate correct per second, using the number of correct trials per second as a derived score. Raw rate scores may range from 0-10, in which a higher score indicates better cognitive flexibility.
Time frame: Baseline and 6 months
Arrow Matching
The investigators will assess 6-month changes in the Mobile Toolbox "Arrow Matching" test as a measure of inhibitory control, a component of executive function (individual cognitive domain). Participants are primary scored on rate correct per second, using the number of correct trials per second as a derived score. Raw rate scores may range from 0-10, in which a higher score indicates better inhibitory control.
Time frame: Baseline and 6 months
Faces and Names
The investigators will assess 6-month changes in the Mobile Toolbox "Faces and Names" test as a measure of associative memory (individual cognitive domain). The test consists of one encoding phase and three memory phases: Face Recognition, Name Recall, and Name Recognition (possible score range for each: 0-12). Total raw scores may range from 0-36, in which a higher score indicates better associative memory.
Time frame: Baseline and 6 months
Body weight
The investigators will assess 6-month changes in body weight (in kg).
Time frame: Baseline and 6 months
Lipid profile
The investigators will assess 6-month changes in lipid profiles, including total cholesterol, low-density lipoprotein cholesterol (Friedewald calculated), high-density lipoprotein cholesterol, and triglycerides. All lipids will be reported as mg/dL.
Time frame: Baseline and 6 months
Fasting blood glucose
The investigators will assess 6-month changes in fasting blood glucose (in mg/dL).
Time frame: Baseline and 6 months
Insulin-like growth factor-1
The investigators will assess 6-month changes of insulin-like growth factor-1 in the blood (in ng/mL).
Time frame: Baseline and 6 months
Interleukin-6
The investigators will assess 6-month changes of interleukin-6 in the blood (in pg/mL).
Time frame: Baseline and 6 months
Arranging Pictures
The investigators will assess 6-month changes in the Mobile Toolbox "Arranging Pictures" test as a measure of episodic memory (individual cognitive domain). This test scores the sum of adjacent pairs correctly placed across two trials. Raw scores range from 0-26 (14 images results in a maximum of 13 adjacent pairs correct per trial), in which a higher score indicates better episodic memory.
Time frame: Baseline and 6 months
Sequences
The investigators will assess 6-month changes in the Mobile Toolbox "Sequences" test as a measure of working memory (individual cognitive domain). This score is the total number of items (individual sequence) correctly answered. The possible raw score range is 0-30, in which a higher score indicates better working memory.
Time frame: Baseline and 6 months
Number-Symbol Match
The investigators will assess 6-month changes in the Mobile Toolbox "Number-Symbol Match" test as a measure of processing speed (individual cognitive domain). The test includes 144 total items, with up to 16 successive screens of 9 items each presented, and examinees have 90 seconds to complete as many items as possible. This score is the total number of items correctly answered in 90 seconds. The possible raw score range is 0-144, in which a higher score indicates better processing speed.
Time frame: Baseline and 6 months
Waist circumference
The investigators will assess 6-month changes in waist circumference (in cm).
Time frame: Baseline and 6 months
Lutein
The investigators will assess 6-month changes in serum lutein (in µmol/L) as a marker of compliance with pistachio consumption. Participants in the pistachio group are expected to have increases in serum lutein levels, while participants in the usual group are expected to have no changes.
Time frame: Baseline and 6 months
Gamma tocopherol
The investigators will assess 6-month changes in serum gamma tocopherol (mg/L) as a marker of compliance with pistachio consumption. Participants in the pistachio group are expected to have increases in serum gamma tocopherol levels, while participants in the usual group are expected to have no changes.
Time frame: Baseline and 6 months
Plan to share: Undecided
Started May 2025 (actual). Primary completion is estimated for Mar 2027, 22 months after the start.
Of 250 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's planned 22 months is above that.
Counting every sponsor, half of 257 studies reached it within 9 months; a quarter within 3 and three quarters within 21.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Nov 2026 → Mar 2027 and completion Nov 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital →